- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic obstructive pulmonary disease (COPD)
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 383KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 62KB)
Tiotropium – March 2024
Tiotropium: Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate); Tiotropium Lupin
Last updated
30 May 2025